TREM2 and neoplasm: Lastly, heterogeneity in TREM2 gene expression and mutations raises the possibility of off-tumor risks or long-term effects on central immune regulation, necessitating careful patient screening and extended follow-up in clinical settings (143, 145, 150, 153, 155).